Infinity Pharmaceuticals | INFI - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.53B 4.47B 2026-03
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
J&J USD 59.17B 3.55B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Plus Therapeutics USD 15.17M 2.42M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 1.09B 456.2M 2026-03